Literature DB >> 31387142

Estimating Centre for Disease Control and Prevention-defined overdose risk in people prescribed opioids for chronic non-cancer pain: implications for take-home naloxone provision.

Nicholas Lintzeris1,2,3, Thomas Santo3, Suzanne Nielsen3,4, Louisa Degenhardt3, Gabrielle Campbell3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31387142      PMCID： PMC7004747          DOI： 10.1111/imj.14386

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  4 in total

1.  Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids.

Authors:  Suzanne Nielsen; Amy Peacock; Nicholas Lintzeris; Raimondo Bruno; Briony Larance; Louisa Degenhardt
Journal:  Pain Med       Date:  2018-03-01       Impact factor: 3.750

2.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  MMWR Recomm Rep       Date:  2016-03-18

3.  The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain.

Authors:  Gabrielle Campbell; Suzanne Nielsen; Raimondo Bruno; Nicholas Lintzeris; Milton Cohen; Wayne Hall; Briony Larance; Richard P Mattick; Louisa Degenhardt
Journal:  Pain       Date:  2015-02       Impact factor: 6.961

4.  An overview of take-home naloxone programs in Australia.

Authors:  Robyn Dwyer; Anna Olsen; Carrie Fowlie; Chris Gough; Ingrid van Beek; Marianne Jauncey; Nicholas Lintzeris; Grace Oh; Jane Dicka; Craig L Fry; Jeremy Hayllar; Simon Lenton
Journal:  Drug Alcohol Rev       Date:  2018-05
  4 in total
  1 in total

1.  A new side-effect of sufentanil: increased monocyte-endothelial adhesion.

Authors:  Dongdong Yuan; Zhaowei Zou; Xianlong Li; Nan Cheng; Na Guo; Guoliang Sun; Dezhao Liu
Journal:  BMC Anesthesiol       Date:  2021-11-03       Impact factor: 2.217
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.